We have observed
10 EP applications
Rachel Clare Williams
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 23, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ALBUMIN FORMULATION AND USE
PHARMACOKINETIC ANIMAL MODEL
ALBUMIN VARIANTS BINDING TO FCRN
ALBUMIN VARIANTS AND CONJUGATES
IMPROVED PROTEIN EXPRESSION STRAINS